University of Thessaly (UTH)
Επιγενετικοί μηχανισμοί στην εκφυλιστική νόσο των αρθρώσεων
Abstract
dc:descriptionOsteoarthritis (OA) is defined as a chronic, multifactorial, degenerative joint disease. Advanced age comprises the main risk factor in the development of OA, accompanied by modifications in all joint tissues that mainly involve cellular senescence and progressive degradation of the extracellular matrix, inflammation of the synovial fluid and dysregulation of the metabolic homeostasis of articular chondrocytes. In addition to aging, OA is a disease with a strong genetic component, as 50% of its incidence is attributed to heredity which, however, does not seem to adequately explain the aetiology of the disease. In an effort to clarify the underlying molecular mechanisms and gene regulation networks involved in the development of OA, currently the research has focused on epigenetics, that describes heritable phenotypic modifications that do not result from alterations in DNA sequence. A key molecule in the aetiology of OA is sirtuin 1 (SIRT1), which is a highly conserved NAD+ dependent histone and non-histonic protein deacetylase, as it regulates chondrocyte metabolic functions, inflammatory responses, mitochondrial biogenesis, senescence and apoptosis through deacetylation of its substrates, such as transcription factors and acetylated histones. It has been previously shown that in chronic inflammatory and age-related morbidities, including OA, where oxidative stress is increased, SIRT1 shows decreased expression levels, thus causing metabolic imbalance and increased inflammatory and catabolic activity in OA chondrocytes. The aim of the present PhD thesis was to investigate the epigenetic mechanisms involved in the regulation of SIRT1 expression and deacetylase activity in human OA chondrocytes. The experimental design of the thesis is composed of two parts. The first part investigated the role of DNA methylation in the regulation of SIRT1. The methylation pattern of SIRT1 promoter was analyzed in normal and OA chondrocytes using bisulfite DNA sequencing. Next, the binding affinity of the transcription factor C/EBPα to SIRT1 promoter was assessed by Chromatin immunoprecipitation (ChIP) assay. The interaction of C/EBPα and SIRT1 promoter, as well as SIRT1 expression levels were evaluated after treatment of OA chondrocytes with 5-Aza-2-Deoxycytidine (5-AzadC). The acetylation and nuclear levels of the p65 subunit of transcription factor Nuclear factor kappa-B (NF-κBp65), and the expression levels of the inflammatory mediators, interleukin 1β (IL-1β), IL-6 and TNFα, and catabolic genes (metalloproteinase- 1 (MMP-1) and MMP-9) and aggrecanase ADAMTS-5, were evaluated in OA chondrocytes treated with 5-AzadC, with or without subsequent transfection with siRNA against SIRT1. The second part investigated the role of a small non-coding RNA, miR-217-5p, in SIRT1 regulation in OA chondrocytes. MiR-217-5p gene-target prediction and enrichment analyses were performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways databases, while miR-217-5p expression levels were assessed in normal and OA chondrocytes. SIRT1 mRNA and protein expression levels, NF-κBp65 and p53 acetylation levels and the expression levels of inflammatory mediators [IL-1β, IL-6, TNFα], cartilage matrix regulating genes [MMP-1, MMP-9, MMP-13, COL2A1, ACAN] and pro-apoptotic markers [Bax, pro-caspase-3, cleaved caspase-3] associated with OA, were evaluated in OA chondrocytes treated with miR-217 mimic, as well as in miR-217 inhibitor-treated OA chondrocytes, with or without subsequent transfection with siRNA against SIRT1. The results of the first part of the research demonstrated hypermethylation of specific CpG dinucleotides on SIRT1 promoter, which was associated with decreased SIRT1 expression in OA chondrocytes. In addition, reduced binding ability of C/EBPα to the hypermethylated regions of SIRT1 promoter was observed. Treatment of OA chondrocytes with 5-AzadC restored C/EBPα transcriptional activity, inducing SIRT1 expression. Deacetylation of NF-κBp65 in OA chondrocytes treated with 5-AzadC was prevented by siSIRT1 transfection. Similarly, OA chondrocytes treated with 5-AzadC showed decreased expression of IL-1β, IL-6, MMP-1, and MMP-9 that was reversed after treating OA chondrocytes with 5-AzadC/siSIRT1. Concurrently, miR-217 target prediction and enrinchment analyses showed that SIRT1 is a miR-217 target-gene involved in OA pathology, while miR-217-5p directly targets SIRT1 mRNA with complete complimentarity. Mir-217-5p is overexpressed in OA chondrocytes, which partialty explains the observed downregulation of SIRT1 in OA chondrocytes. MiR-217 mimic transfection showed opposing results with miR-217 inhibitor treatment. Deacetylation of NF-κBp65 and p53 in OA chondrocytes treated with miR-217 inhibitor was reversed upon siSIRT1 tranfection, while OA chondrocytes treated with miR-217 inhibitor showed increased expression of COL2A1 and ACAN, and decreased expression of IL-1β, IL-6, TNFα, MMP-1, MMP-9, MMP-13, Bax, and cleaved caspase-3, which was reversed after miR-217 inhibitor/siSIRT1 treatment. In summary, the results of the present thesis highlight the effect of DNA methylation and miR-217-5p in suppressing SIRT1 deacetylase, which disrupts its protective anti-catabolic, anti-inflammatory and anti-apoptotic effects in OA chondrocytes, and further contributes to OA pathogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papageorgiou, Aliki-Alexandra
- Παπαγεωργίου, Αλίκη-Αλεξάνδρα
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56263